prostate cancer index | prostate cancer | prostatectomy | radiation | hormone | cryosurgery | hifu | wait & see | alternative treatment | diet | articles | contact |

Archive for February, 2012

Pomegranates may help prevent prostate cancer

Wednesday, February 29th, 2012 Posted in alternative treatments | No Comments »

Pomegranates rank high among fruits for antioxidant and anti-inflammatory effects because of their vitamin C and phytochemical compounds. The laboratory evidence shows that substances, called urolithins, that our body produces from pomegranates' compounds can decrease prostate cancer cell growth and ...

Prostate cancer treatment overused in some older patients

Tuesday, February 28th, 2012 Posted in prostate cancer | No Comments »

Yale School of Medicine researchers report in the Feb. 27 Archives of Internal Medicine that treatment is not always warranted for older men with prostate cancer and a short life expectancy. They suggests that among men who are older and ...

Docetaxel with or without estramustine for estramustine phosphate in castration-resistant prostate cancer

Sunday, February 26th, 2012 Posted in prostate cancer | No Comments »

The significance of combination of docetaxel (DTX) with estramustine phosphate (EMP) in castration-resistant prostate cancer (CRPC) patients remains unclear. A new study aimed to retrospectively evaluate the efficacy and toxicity of DTX with or without EMP and to elucidate the significance of ...

Cancer therapy more potent when it hits 2 targets

Friday, February 24th, 2012 Posted in prostate cancer | No Comments »

Simultaneous targeting of two different molecules in cancer is an effective way to shrink tumors, block invasion, and stop metastasis, scientists at the University of California, San Francisco (UCSF) have found—work that may improve the effectiveness of combination treatments that ...

Precision prostate cancer treatment

Wednesday, February 22nd, 2012 Posted in radiation therapy | No Comments »

Prostate cancer starts in the prostate gland; and it occurs when cells in the prostate gland grow out of control. Prostate cancer is the most common form of cancer found in men and about one in every six men will ...

HIFU does not provide effective oncologic outcomes; Korean study concluded

Tuesday, February 21st, 2012 Posted in radiation therapy | No Comments »

A new paper by clinical researchers in Korea has concluded that treatment with high-intensity focused ultrasound (HIFU) “does not provide effective oncologic outcomes even in low risk patients with prostate cancer as well as in the intermediate or high risk ...

Botanical formula effective in treating prostate cancer

Monday, February 20th, 2012 Posted in alternative treatments | No Comments »

A study at Indiana University, Methodist Research Institute examined a botanical formula containing botanical extracts, phytonutrients, botanically-enhanced medicinal mushrooms and antioxidants. The study findings demonstrate that the prostate formula substantially inhibited tumor growth in aggressive, hormone refractory, androgen independent human-prostate cancer ...

Men opting for costly new prostate cancer treatment

Sunday, February 19th, 2012 Posted in Uncategorized | No Comments »

Men diagnosed with localized prostate cancer are more likely to be treated with proton beam therapy, a novel form of radiation therapy, if the technology is available nearby, a new study found. The treatment is often billed as having lower impotence ...

Study questions prostate cancer therapy

Saturday, February 18th, 2012 Posted in radiation therapy | No Comments »

In a new study, records of Medicare patients with prostate cancer show that those treated with a more precise form of radiation known as proton therapy had more bowel complications, such as bleeding, than those who underwent the conventional technique. "Proton ...

Four new drugs will change prostate cancer care

Thursday, February 16th, 2012 Posted in prostate cancer | No Comments »

Four new drugs Denosumab,Alpharadin, Prostvac and Abiraterone Acetate mark first major advances in prostate cancer care in nearly 15 years. New targeted drugs act in novel and interesting ways, not just chemo They could transform prostate cancer from terminal to chronic disease